You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Introduction to ASAM

OVERVIEW OF THE ASAM CRITERIA

This 15-hour training is designed to provide a broad overview of The ASAM Criteria for addiction and mental health treatment providers and other important stakeholders. It is designed to effectively educate stakeholders that play a role in the behavioral healthcare service delivery system using a standardized placement roadmap with guiding principles, dimensional assessment and levels of care service plans for continued stay or transfer and discharge services.


 MODULE 101

 1. ASAM Module 101-basic knowledge
  - Review the underlying concepts and principles of the ASAM Criteria
  - Discuss changes made in the Revised Third Edition of the ASAM Criteria, that includes the DSM 5 changes inform diagnosis and co-occurring mental and substance related disorders
 

MODULE 102

 1. ASAM Module 102-Assessing the Client
  - Decision Flow to Match and Focus Assessment and Treatment
  - Identifying the Assessment and Treatment Contract
  - Assessment Criteria in the Levels of Care
  - Co-Occurring Services
  - The Concept of “Unbundling”
  - A word About the Stages of Change
  - Case management

 MODULE 103

  ASAM Module 103-Assessing the Participant
  - Residential Levels of Care
  - Continued Services, Discharges and Transfers
  - Case Examples

 

Training Dates 

 February 15, 2023

 February 22, 2023

 March 1, 2023

 March 8, 2023

 March 15, 2023

 March 22, 2023


PRESENTER

PhotoSabrina A. Poole, Psy.D., has 30+ years of experience in the addiction psychology field. She has directed numerous studies for the Center on the Studies of Addiction and the Treatment Research Center of Philadelphia, and offers application support for the Addiction Severity Assessment and ASAM Criteria. She is a graduate of State University College at Buffalo and has a Psy.D. Degree in Clinical Psychology. Expert support in the development and management of study protocols, client recruitment and assessment, and outcomes measurement. Includes study start-up, Institutional Review Board (IRB) submissions and FDA Investigational New Drug (IND) applications support. Also includes project staffing and laison between local and national Grantors (i.e., local city boards and National Institutes on Health/ National Institute on Drug Abuse).

 

 

** THIS IS A CLOSED EVENT**

 

Starts: Feb. 15, 2023 9:00 am
Ends: Mar. 22, 2023 11:30 am
Timezone:
US/Eastern
Event Type
Webinar/Virtual Training
Hosted by
Contact Us for More Info
map-markercalendar-fullmagnifiercrossmenuchevron-down